Long-term safety and effectiveness of eptinezumab in patients with prior preventive migraine treatment failures

被引：0
|
作者：
Ashina, M. [1 ,2 ]
Tepper, S. J. [3 ]
Gendolla, A. [4 ]
Sperling, B. [5 ]
Ettrup, A. [5 ]
Josiassen, M. K. [5 ]
Starling, A. J. [6 ]
机构：
[1] Univ Copenhagen, Dept Neurol, Copenhagen, Denmark
[2] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[3] Dartmouth Hitchcock Med Ctr, Lebanon, NH USA
[4] Praxis Gendolla, Essen, Germany
[5] H Lundbeck & Co AS, Copenhagen, Denmark
[6] Mayo Clin Arizona, Scottsdale, AZ USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P074
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-term safety and effectiveness of eptinezumab in patients with prior preventive migraine treatment failures
    Ashina, Messoud
    Tepper, Stewart J.
    Gendolla, Astrid
    Sperling, Bjorn
    Ettrup, Anders
    Josiassen, Mette Krog
    Starling, Amaal J.
    CEPHALALGIA, 2023, 43 (1supp) : 45 - 45
  • [2] Long-term effectiveness of eptinezumab in patients with prior preventive migraine treatment failures
    Ashina, M.
    Tepper, S.
    Gendolla, A.
    Sperling, B.
    Ettrup, A.
    Josiassen, M.
    Starling, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 372 - 372
  • [3] Long-term effectiveness of eptinezumab in patients with prior preventive migraine treatment failures
    Starling, A.
    Ashina, M.
    Tepper, S.
    Gendolla, A.
    Sperling, B.
    Ettrup, A.
    Josiassen, M.
    HEADACHE, 2023, 63 : 144 - 145
  • [4] Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial
    Messoud Ashina
    Stewart J. Tepper
    Astrid Gendolla
    Bjørn Sperling
    Anders Ettrup
    Mette Krog Josiassen
    Amaal J. Starling
    The Journal of Headache and Pain, 24
  • [5] Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial
    Ashina, Messoud
    Tepper, Stewart J.
    Gendolla, Astrid
    Sperling, Bjorn
    Ettrup, Anders
    Josiassen, Mette Krog
    Starling, Amaal J.
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [6] Efficacy and Safety of Eptinezumab for Migraine Prevention in Patients With 2-4 Prior Preventive Treatment Failures
    Ashina, M.
    Lanteri-Minet, M.
    Pozo-Rosich, P.
    Ettrup, A.
    Christoffersen, C. L.
    Josiassen, M. K.
    Phul, R.
    Sperling, B.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [7] Efficacy and Safety of Eptinezumab for Migraine Prevention in Patients With 2-4 Prior Preventive Treatment Failures
    Ashina, M.
    Lanteri-Minet, M.
    Pozo-Rosich, P.
    Ettrup, A.
    Christoffersen, C.
    Josiassen, M.
    Phul, R.
    Sperling, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 418 - 418
  • [8] Efficacy and safety of eptinezumab for migraine prevention in patients with 2-4 prior preventive treatment failures
    Ashina, M.
    Lanteri-Minet, M.
    Pozo-Rosich, P.
    Ettrup, A.
    Boyle, L.
    Christoffersen, C.
    Josiassen, M.
    Phul, R.
    Sperling, B.
    HEADACHE, 2022, 62 : 141 - 142
  • [9] Long-term reductions in acute headache medication use after eptinezumab treatment in patients with prior preventive treatment failures
    Gryglas-Dworak, A.
    Schim, J.
    Ettrup, A.
    Boserup, L. P.
    Josiassen, M. K.
    Ranc, K.
    Sperling, B.
    Ashina, M.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [10] Long-term reductions in acute headache medication use after eptinezumab treatment in patients with prior preventive treatment failures
    Gryglas-Dworak, Anna
    Schim, Jack
    Ettrup, Anders
    Boserup, Line Pickering
    Josiassen, Mette Krog
    Ranc, Kristina
    Sperling, Bjorn
    Ashina, Messoud
    CEPHALALGIA, 2023, 43 (1supp) : 46 - 47
12345